S&P 500 (NYSE:SPY) component McKesson Corp (NYSE:MCK) will unveil its latest earnings on Monday, April 30, 2012. McKesson delivers cost-reducing medicines, pharmaceutical supplies, information, and care management products and services.
McKesson Corp Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for net income of $2.06 per share, a rise of 24.1% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $2.07. Between one and three months ago, the average estimate moved down. It has risen from $2.05 during the last month. Analysts are projecting profit to rise by 29.8% versus last year to $6.36.
Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 2 cents, reporting profit of $1.40 per share against a mean estimate of net income of $1.38 per share.
Investing Insights: What’s the Future of Microsoft’s Stock?
Wall St. Revenue Expectations: Analysts predict a rise of 5.4% in revenue from the year-earlier quarter to $30.4 billion.
Analyst Ratings: Analysts are bullish on this stock, with 11 analysts rating it as a buy, none rating it as a sell and three rating it as a hold.
A Look Back: In the third quarter, profit rose 93.5% to $300 million ($1.20 a share) from $155 million (60 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 9.2% to $30.84 billion from $28.25 billion.
On the top line, the company is looking to build on four-straight revenue increases heading into this earnings announcement. Revenue rose 8.3% in the fourth quarter of the last fiscal year, 9.2% in the first quarter and 9.7% in the second quarter before increasing again in the third quarter.
Heading into this earnings announcement, the company is trying build on some positive momentum from last quarter’s income increase. After net income declines in the first quarter and second quarter, profit rose in the third quarter.
Stock Price Performance: Between January 27, 2012 and April 24, 2012, the stock price rose $11.86 (15%), from $79.12 to $90.98. The stock price saw one of its best stretches over the last year between March 2, 2012 and March 16, 2012, when shares rose for 11 straight days, increasing 6.6% (+$5.39) over that span. It saw one of its worst periods between November 15, 2011 and November 25, 2011 when shares fell for eight straight days, dropping 7.8% (-$6.44) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories: